Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
MIRA Pharmaceuticals, Inc. (MIRA) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-22.69M |
|
-- |
|
-- |
|
$1.32M |
|
$-1.32M |
|
$0.18M |
|
$-1.14M |
|
$-1.31M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.31M |
|
$-1.32M |
|
$-1.32M |
|
19.27M |
|
19.27M |
|
$-1.18 |
|
$-1.18 |
|
| Balance Sheet Financials | |
$7.60M |
|
-- |
|
$0.04M |
|
$7.63M |
|
$0.08M |
|
-- |
|
-- |
|
$0.08M |
|
$7.55M |
|
$7.55M |
|
$7.55M |
|
39.51M |
|
| Cash Flow Statement Financials | |
$-3.53M |
|
-- |
|
$3.34M |
|
$2.83M |
|
$2.64M |
|
$-0.19M |
|
$1.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
90.53 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.07% |
|
-15.07% |
|
-14.90% |
|
-15.07% |
|
$0.19 |
|
$-0.18 |
|
$-0.18 |
|